I think you should read up on what it is like to live with asthma. Then you will understand the need for Respiri management tool which will use a smartphone to record datA on a daily basis using a hand held device.which monitors wheeze.
Resap is a tool that can diagnose what type of respiratory disease the person has when they present with a problem. They will cough into smart phone and a diagnosis is made. Is it pneumonia or is it a myriad of other problems including asthma? If asthma then they will require the Respri asthma management tool which will help them to manage their condition and hopefully reduce severe attacks.
Therefore imo they are not competitors but will be complementary.
Even if they were competing why try and make an issue here? Competition is healthy and is a natural part of business today.
- Forums
- ASX - By Stock
- RSH
- Ann: CEO Operational Review
Ann: CEO Operational Review, page-10
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RSH (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.6¢ |
Change
-0.001(2.70%) |
Mkt cap ! $46.25M |
Open | High | Low | Value | Volume |
3.7¢ | 3.7¢ | 3.4¢ | $30.95K | 860.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 56464 | 3.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.7¢ | 841626 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 56464 | 0.034 |
2 | 100000 | 0.033 |
3 | 541370 | 0.032 |
2 | 2645161 | 0.031 |
3 | 1447359 | 0.030 |
Price($) | Vol. | No. |
---|---|---|
0.037 | 841626 | 4 |
0.038 | 515624 | 2 |
0.039 | 1482602 | 2 |
0.040 | 340000 | 2 |
0.042 | 882000 | 1 |
Last trade - 16.10pm 30/09/2024 (20 minute delay) ? |
Featured News
RSH (ASX) Chart |